Real-time enrollment status for this amyotrophic lateral sclerosis clinical trial
Current Status
Recruiting
Checked: October 27, 2026 at 8:21 PM UTC
| NCT Number | NCT04220190 |
| Recruiting Status | Recruiting |
| Condition | Amyotrophic Lateral Sclerosis |
| Phase | PHASE2 |
| Target Enrollment | 41 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Rapa Therapeutics LLC |
| Last Updated on CT.gov | September 29, 2026 (4 weeks ago) |
As of October 27, 2026: Clinical trial NCT04220190 is currently recruiting participants. This phase2 study for amyotrophic lateral sclerosis is actively seeking new participants at 1 location across the United States. The study is sponsored by Rapa Therapeutics LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04220190 is actively recruiting participants as of October 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04220190 was last updated 4 weeks ago (September 29, 2026). HelloStudys verifies this status automatically.